GSTM1 and tuberculosis: A previous study of our group had demonstrated, using routine clinical laboratory parameters, that anemia is a risk factor for unfavorable anti-TB treatment outcomes, and that Hb levels are associated with a heightened degree of inflammatory perturbation in TB-HIV patients (9).